Timothy Turner, Ph.D.
Location: Carver Research Foundation, Room 6
Office Phone: 334-727-8787
E-mail: TURNER@mytu.tuskegee.edu

Biographical Sketch:

Dr. Timothy Turner, Professor of Biology, is the Deputy Director of Research and Training in the Tuskegee University National Center for Bioethics in Research and Health Care, Program Director of the Center for Biomedical Research/Research Centers at Minority Institutions, and the Lead Principal Investigator for the MSM/TU/UAB CCC Partnership. Turner received his B.S. degree in biology from Jackson State University, Jackson, MS and his Ph.D. degree in endocrinology and tumor biology from the University of California, Berkeley. His research interests focus on identifying and disrupting signaling mechanisms involved in the progression of prostate cancer to its invasive and metastatic stages. Within this approach, his lab has utilized luteinizing hormone releasing hormone receptors as the tumor target for the delivery of cancer drugs to prostate cancer cells. In addition to his administrative, research and teaching obligations, another of Dr. Turner’s focus is to increase biomedical and cancer research ongoing at Tuskegee University to promote the reduction of health disparities affecting African-Americans.

Research Fields:

• Identifying and disrupting signaling mechanisms  involved in the cancer progression

• Targeted cancer drug delivery


Dr. Alan Wells, University of Pittsburgh School of Medicine, University of Pittsburgh, Carnegie Mellon University

Dr. Uppender Manne, Department of Pathology, University of Alabama at Birmingham

Dr. James Lillard, Department of Microbiology, Biochemistry, & Immunology, Morehouse School of Medicine

Dr. Richard Allman, Department of Medicine, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham

Representative Publications:

1. Abdalla, M.O., Aneja, R., Dean, D., Rangari, V., Russell, A., Jaynes, J., Yates, C., and Turner, T. (2010). Synthesis and Characterization of Noscapine-Loaded Magnetic Polymer Nanoparticles. Journal of Magnetism and Magnetic Materials, 322: 190-196. PMID: 20161408; PMCID: PMC2784924

2. Theodore, S.C., Rhim, J., Turner, T., and Yates, C. (2010). miRNA 26a Expression in a Novel Panel of African American Prostate Cancer Cell Lines. Journal of Ethnicity & Disease, 20: 96-100. PMID: 20521394; PMCID: PMC3118047

3. Yates, C.C., Krishna, P., Whaley, D., Bodnar, R.J., Turner, T., and Wells, A. (2010). Lack of CXC Chemokine Receptor 3 Signaling Leads to Hypertrophic and Hypercellular Scarring. American Journal of Pathology, 176: 1743-1755. PMID: 20203286; PMCID: PMC2843466